UBS Maintains Neutral on FMC, Lowers Price Target to $10

Benzinga Newsdesk www.benzinga.com Negative 65.6%

Neg 65.6% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $12 to $10.

Comments

No comments yet. Be the first!